Looking at top Wall Street opinions, British American Tobacco p.l.c. (NYSE: BTI) has recently made its way into the research list of Piper Jaffray – signaling that their analyst’s rating adjustment is noteworthy. This stock was downgraded to a rating of Neutral in the eyes of Piper Jaffray, whereas its previous rating was Overweight in the eyes of Piper Jaffray, as reported on Thursday, July 11th, 2019. Another heavy-hitting research note was published by Morgan Stanley on Monday June 17th, 2019, with this firm downgrading BTI to an updated rating of Underweight from its previous rating of Equal-Weight. In the past six months and three months of trading, shares of British American Tobacco p.l.c. (BTI) have moved by 3.46% and -1.21%, respectively.
Brokerage Updates Related to British American Tobacco p.l.c. (BTI) Stock
This publicly-traded organization generated gains of 1.38% over the last 5 sessions. Right now, this stock is the subject of 4 analysts’ evaluations, who – on average – have given this company’s shares a Buy rating. Of the latest market expert opinions, 1 have given an underperform rating, 0 has given a sell rating, and 2 have given a rating of Buy or better. Based on the 4 stock market experts following this company, the average 12-month price target is $46.96. Moreover, individual price targets range between $46.01-$62.88. With its recent move to $54.45, we can see that these firms project this stock will loss by -31.13% in one year.
Updates from British American Tobacco p.l.c. (BTI) SEC Form 4
This particular company’s shares have garnered a lot of attention in recent days, as insiders are unloading their holdings while having generated a 4.60% rise since the beginning of the calendar year.
JPMorgan Chase & Co. (NYSE:JPM) experienced a gain of 1.54% from the closing price in the previous trading day. That boost the price to $109.34 per share, as observed on January 1st, 1970, at a time when the total trading volume reached 12,153,124 shares of stock – compared to the typical average of 11.32M shares per day (as recorded over the past three months). The consensus estimate for these shares has been shifted to $121.27.
Pricing Indications for JPMorgan Chase & Co. (JPM)
This organization has had a price-to-earnings ratio of 11.13 in the last year. Meanwhile, it gained 111.90 from its observable 50-day simple moving average. Right at this moment, the per-share value is 1.89% higher than the mean per-share price over the last 200 days in the market.
JPMorgan Chase & Co. (NYSE:JPM) In-Depth Brokerage Insights
We can see that a number of brokerage firms are putting their focus onto this stock. Out of this group, 1 have a sell rating, 8 have a Buy rating, 7 have an outperform rating, while 13 provided a Hold rating for these shares – thanks to data from Thomson Reuters I/B/E/S. Additionally, 0 have recommended that these shares are an Underperforming investment. The current consensus recommendation is at 2.30, based on information from Thomson Reuters.
JPM Stock Value Potential
In trading activity as of late, this stock’s value was 107.35 up from its 200 day moving average, while also -2.24% down when compared against its 50-day simple moving average. Over the course of the past year of trading, the share price stuck in the range of $85.00-$141.00. The market value for the entire organization reached 350.00B. In the last trading session, the price ended the day at $107.68. The institutional holdings related to this organization account for 0.10%, and the Beta factor is now 1.17. This company’s RSI (Relative Strength Index) managed to hit 42.15.
JPMorgan Chase & Co. (NYSE:JPM) Analyst Points of Focus
JPMorgan Chase & Co. (JPM) has found itself inside of Jefferies’s research list, so their analyst rating adjustment is worth taking note of. This stock was downgraded to Hold, compared to its previous rating of Buy by Jefferies, as garnered from a news report on Tuesday January 8th, 2019. An additional helpful research note was sent out by Barclays’s on Wednesday January 2nd, 2019. The brokerage decided to reiterated JPM to Overweight.